PBPIA
VIGL
Pivotal bioVenture Partners Investment Advisor’s Vigil Neuroscience VIGL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.46M | Hold |
560,595
| – | – | 2.76% | 7 |
|
2025
Q1 | $998K | Hold |
560,595
| – | – | 0.81% | 9 |
|
2024
Q4 | $953K | Hold |
560,595
| – | – | 0.64% | 10 |
|
2024
Q3 | $1.91M | Hold |
560,595
| – | – | 1.13% | 9 |
|
2024
Q2 | $2.24M | Hold |
560,595
| – | – | 1.72% | 7 |
|
2024
Q1 | $1.91M | Hold |
560,595
| – | – | 1.23% | 9 |
|
2023
Q4 | $1.89M | Hold |
560,595
| – | – | 0.48% | 11 |
|
2023
Q3 | $3.02M | Hold |
560,595
| – | – | 1.21% | 10 |
|
2023
Q2 | $5.27M | Hold |
560,595
| – | – | 1.74% | 8 |
|
2023
Q1 | $5.49M | Hold |
560,595
| – | – | 2.26% | 8 |
|
2022
Q4 | $7.01M | Hold |
560,595
| – | – | 3.05% | 5 |
|
2022
Q3 | $5.1M | Hold |
560,595
| – | – | 1.86% | 8 |
|
2022
Q2 | $1.45M | Hold |
560,595
| – | – | 0.73% | 10 |
|
2022
Q1 | $3.94M | Buy |
+560,595
| New | +$3.94M | 1.86% | 10 |
|